BOTOX better make way for some heated competition. The FDA has recently approved a new wrinkle-fighting alternative called Dysport that is giving the popular injection treatment a run for its money. Smooth skin seekers have LovelySkin.com's president, Dr. Joel Schlessinger, to thank in large part for Dysport 's availability. While the drug underwent its FDA approval process, his clinic represented one of only a hand selected few in the country to be authorized to perform the clinical studies. During this trial period, Dr. Schlessinger personally worked on Dysport for over five years. As a result, Dr. Schlessinger's clinic in Omaha, Neb., is one of the most experienced facilities in the nation currently offering the new procedure.

According to Dr. Schlessinger, Dysport was known as Reloxin during clinical trials and now is available for treatment of facial wrinkles. Says Schlessinger, "During the study we found that with a few simple injections we could improve an entire area. Additionally, the results last longer than Botox and seem to take effect much quicker! This could truly be the answer to the quick picker upper!"

What sets Dysport apart from BOTOX ? The advantages are threefold. Dysport takes effect in just three days versus the typical seven days it takes BOTOX users to see results. The visual results of the new drug frequently also last a full month longer (or more) than BOTOX (four months vs. three). Finally, and perhaps most appealing, Dysport is more economical in most practices than BOTOX .

Indeed, "according to national surveys done by the American Society for Aesthetic Plastic Surgery, the average cost of a single BOTOX treatment was just about $501 in 2007." Schlessinger states, "Many practitioners will be charging less for this drug than Botox due to the competition in this arena and this is a great thing for patients. My guess is that this may even drive Botox prices down in the long run."

Despite the fact that this is new, there are a cadre of dermatologists and plastic surgeons who have experience with this drug and participated in the clinical trials that Schlessinger was active in for over five years. It is important to check with any clinic offering this procedure to see if the physician has been trained on this new drug and to make sure it is actually the physician who is injecting and not a nurse or non-physician. Schlessinger states that he is part of an educational outreach program that is intended to teach dermatologists and cosmetic surgeons to use this drug properly.

Smooth skin seekers who are looking for a cost-conscious alternative to BOTOX to contend with their wrinkles can learn more about Dysport and all of Dr. Schlessinger's recommended skin care, makeup and beauty products online at http://www.LovelySkin.com. Interested media may arrange an interview by calling (772) 633-8337.

Source: PR-USA